The CRTAC1 protein in plasma associates with prevalent osteoarthritis and predicts future risk as well as progression to joint replacements - Results from the UK Biobank resource.
Unnur StyrkársdóttirSigrun H LundGudmar ThorleifssonSaedis SaevarsdottirDaniel F GudbjartssonUnnur ThorsteinsdottirKari StefanssonPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2022)
CRTAC1 in plasma is specific biomarker of OA, and predictor of OA risk and progression to joint replacements. Adding ACAN and NCAN to CRTAC1 improves the prediction of OA.
Keyphrases